We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Daniel Pratt MD, FAASLD

Daniel S. Pratt MD, FAASLD

Director, Autoimmune and Cholestatic Liver Center, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School, Boston, Massachusetts

Daniel S. Pratt, MD, FAASLD, is Director of the Autoimmune and Cholestatic Liver Center at the Massachusetts General Hospital and an Assistant Professor of Medicine at Harvard Medical School.

Dr. Pratt joined the faculty of the Harvard Medical School and the MGH Gastrointestinal Unit in 2004. He served as the Clinical Director of the MGH Liver Transplant Program from 2012-2021.

Dr. Pratt's clinical and research interests are focused on autoimmune and cholestatic liver disease including primary sclerosing cholangitis, primary biliary cholangitis, and autoimmune hepatitis. Dr. Pratt started the PSC Registry at MGH in 2009.


Dr. Pratt has no relevant disclosures.